Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

SELL
$0.53 - $0.93 $11,240 - $19,724
-21,209 Reduced 65.86%
10,994 $6,000
Q4 2023

Feb 06, 2024

SELL
$0.63 - $1.14 $2,061 - $3,730
-3,272 Reduced 9.22%
32,203 $27,000
Q2 2023

Aug 11, 2023

SELL
$1.31 - $2.04 $9,923 - $15,453
-7,575 Reduced 17.6%
35,475 $56,000
Q1 2023

May 02, 2023

SELL
$1.45 - $2.95 $12,916 - $26,278
-8,908 Reduced 17.14%
43,050 $65,000
Q4 2022

Feb 10, 2023

BUY
$2.02 - $3.25 $14,150 - $22,766
7,005 Added 15.58%
51,958 $125,000
Q3 2022

Nov 09, 2022

BUY
$1.96 - $3.14 $4,264 - $6,832
2,176 Added 5.09%
44,953 $92,000
Q2 2022

Aug 15, 2022

BUY
$1.3 - $2.64 $9,217 - $18,717
7,090 Added 19.87%
42,777 $83,000
Q1 2022

Jun 30, 2022

SELL
$2.35 - $3.47 $5,343 - $7,890
-2,274 Reduced 5.99%
35,687 $88,000
Q4 2021

Feb 15, 2022

BUY
$2.92 - $5.74 $3,390 - $6,664
1,161 Added 3.15%
37,961 $122,000
Q3 2021

Oct 29, 2021

SELL
$4.98 - $6.63 $2,131 - $2,837
-428 Reduced 1.15%
36,800 $193,000
Q2 2021

Aug 16, 2021

BUY
$2.56 - $5.49 $32,430 - $69,547
12,668 Added 51.58%
37,228 $204,000
Q4 2020

Feb 12, 2021

BUY
$3.17 - $4.49 $2,960 - $4,193
934 Added 3.95%
24,560 $78,000
Q3 2020

Oct 30, 2020

BUY
$2.98 - $5.2 $5,280 - $9,214
1,772 Added 8.11%
23,626 $95,000
Q2 2020

Aug 10, 2020

BUY
$2.29 - $4.24 $5,883 - $10,892
2,569 Added 13.32%
21,854 $86,000
Q1 2020

May 13, 2020

BUY
$1.92 - $4.39 $543 - $1,242
283 Added 1.49%
19,285 $47,000
Q3 2019

Nov 13, 2019

SELL
$2.17 - $3.14 $386 - $558
-178 Reduced 0.93%
19,002 $49,000
Q2 2019

Aug 14, 2019

BUY
$2.53 - $3.04 $15,827 - $19,018
6,256 Added 48.41%
19,180 $58,000
Q1 2019

May 15, 2019

BUY
$2.51 - $3.73 $1,159 - $1,723
462 Added 3.71%
12,924 $38,000
Q4 2018

Feb 15, 2019

BUY
$1.59 - $2.66 $19,814 - $33,148
12,462 New
12,462 $30,000
Q3 2018

Nov 14, 2018

SELL
$1.59 - $2.42 $19,407 - $29,538
-12,206 Closed
0 $0
Q2 2018

Jul 18, 2018

BUY
$2.26 - $4.65 $4,431 - $9,118
1,961 Added 19.14%
12,206 $28,000
Q1 2018

May 22, 2018

SELL
$3.51 - $6.04 $217 - $374
-62 Reduced 0.6%
10,245 $48,000
Q4 2017

Feb 13, 2018

BUY
$3.26 - $4.78 $33,600 - $49,267
10,307
10,307 $34,000

Others Institutions Holding AGEN

About AGENUS INC


  • Ticker AGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 283,163,008
  • Market Cap $4.73B
  • Description
  • Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...
More about AGEN
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.